Prudden Holly J, Hamilton Matthew, Foss Anna M, Adams Nicole Dzialowy, Stockton Melissa, Black Vivian, Nyblade Laura
Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Avenir Health, Washington, DC, United States of America.
PLoS One. 2017 Dec 8;12(12):e0189079. doi: 10.1371/journal.pone.0189079. eCollection 2017.
Stigma and discrimination ontinue to undermine the effectiveness of the HIV response. Despite a growing body of evidence of the negative relationship between stigma and HIV outcomes, there is a paucity of data available on the prevalence of stigma and its impact. We present a probabilistic cascade model to estimate the magnitude of impact stigma has on mother-to-child-transmission (MTCT).
The model was parameterized using 2010 data from Johannesburg, South Africa, from which loss-to-care at each stage of the antenatal cascade were available. Three scenarios were compared to assess the individual contributions of stigma, non-stigma related barriers, and drug ineffectiveness on the overall number of infant infections. Uncertainty analysis was used to estimate plausible ranges. The model follows the guidelines in place in 2010 when the data were extracted (WHO Option A), and compares this with model results had Option B+ been implemented at the time.
The model estimated under Option A, 35% of infant infections being attributed to stigma. This compares to 51% of total infections had Option B+ been implemented in 2010. Under Option B+, the model estimated fewer infections than Option A, due to the availability of more effective drugs. Only 8% (Option A) and 9% (Option B+) of infant infections were attributed to drug ineffectiveness, with the trade-off in the proportion of infections being between stigma and non-stigma-related barriers.
The model demonstrates that while the effect of stigma on retention of women at any given stage along the cascade can be relatively small, the cumulative effect can be large. Reducing stigma may be critical in reaching MTCT elimination targets, because as countries improve supply-side factors, the relative impact of stigma becomes greater. The cumulative nature of the PMTCT cascade results in stigma having a large effect, this feature may be harnessed for efficiency in investment by prioritizing interventions that can affect multiple stages of the cascade simultaneously.
耻辱感和歧视继续削弱艾滋病应对措施的有效性。尽管越来越多的证据表明耻辱感与艾滋病相关结果之间存在负面关系,但关于耻辱感的流行程度及其影响的数据却很匮乏。我们提出了一个概率级联模型,以估计耻辱感对母婴传播(MTCT)的影响程度。
该模型使用了来自南非约翰内斯堡的2010年数据进行参数化,从中可以获得产前级联每个阶段的失访情况。比较了三种情景,以评估耻辱感、非耻辱感相关障碍和药物无效性对婴儿感染总数的个体贡献。使用不确定性分析来估计合理范围。该模型遵循2010年提取数据时的现行指南(世卫组织A方案),并将其与当时实施B+方案时的模型结果进行比较。
该模型估计,在A方案下,35%的婴儿感染归因于耻辱感。相比之下,如果2010年实施B+方案,这一比例将占总感染数的51%。在B+方案下,由于有更有效的药物,模型估计的感染数比A方案少。只有8%(A方案)和9%(B+方案)的婴儿感染归因于药物无效性,感染比例的权衡存在于耻辱感和非耻辱感相关障碍之间。
该模型表明,虽然耻辱感对级联中任何给定阶段妇女留存率的影响可能相对较小,但累积影响可能很大。减少耻辱感对于实现消除母婴传播目标可能至关重要,因为随着各国改善供应方因素,耻辱感的相对影响会变得更大。预防母婴传播级联的累积性质导致耻辱感产生很大影响,这一特征可通过优先考虑能够同时影响级联多个阶段的干预措施来提高投资效率。